Protein aggregation and ER stress

Area of Science:

• Neuroscience
• Molecular Biology
• Cellular Biology

Background:

• Protein misfolding and aggregation are hallmarks of neurodegenerative diseases like Alzheimer's and Parkinson's.
• Endoplasmic reticulum (ER) stress is increasingly recognized as a key factor in the cytotoxicity of these disorders.
• Current therapies for neurodegenerative diseases are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To review recent findings on the mechanisms linking protein aggregation to ER stress in neurodegenerative diseases.
• To discuss the significance of ER stress in disease pathogenesis.
• To explore potential therapeutic approaches targeting ER stress.

Main Methods:

• Literature review of recent research on protein aggregation and ER stress.
• Analysis of studies investigating toxic species in neurodegenerative diseases.
• Examination of therapeutic strategies targeting ER stress pathways.

Main Results:

• Protein aggregation, involving proteins like amyloid-β, tau, α-synuclein, and huntingtin, follows a common pathway of oligomerization and fibril formation.
• Intermediate oligomeric forms of aggregated proteins are identified as the primary toxic species and inducers of ER stress.
• Final amyloid aggregates are less implicated in ER stress and cytotoxicity compared to oligomeric intermediates.

Conclusions:

• Protein aggregation-induced ER stress is a critical mechanism in neurodegenerative disease pathology.
• Targeting intermediate oligomeric species and mitigating ER stress presents a promising therapeutic avenue.
• Further research into these mechanisms could lead to effective treatments for debilitating neurodegenerative conditions.